Robert Pytela
Plus aucun poste en cours
Profil
Robert Pytela is associated with two companies, Epitomics, Inc. and Calico Biolabs, Inc., both of which he founded in 2001 and 2011 respectively.
Anciens postes connus de Robert Pytela
| Sociétés | Poste | Fin |
|---|---|---|
Calico Biolabs, Inc.
 Calico Biolabs, Inc. Medical/Nursing ServicesHealth Services Part of Abcam Plc, Calico Biolabs, Inc. is a company that develops custom rabbit monoclonal antibodies for research and diagnostic use. The company is based in Pleasanton, CA. The company was founded in 2011 by Robert Pytela. The CEO is Emma Sceats. Calico Biolabs was acquired by Abcam Plc on January 28, 2019. | Fondateur | - |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Health Technology |
Calico Biolabs, Inc.
Calico Biolabs, Inc. Medical/Nursing ServicesHealth Services Part of Abcam Plc, Calico Biolabs, Inc. is a company that develops custom rabbit monoclonal antibodies for research and diagnostic use. The company is based in Pleasanton, CA. The company was founded in 2011 by Robert Pytela. The CEO is Emma Sceats. Calico Biolabs was acquired by Abcam Plc on January 28, 2019. | Health Services |
